Eagle Pharmaceuticals, Inc. (EGRX)
Market Closed
15 Jun, 17:13
OTC PINK OTC PINK Primary $
0. 61
+0.02
+2.5%
$
8.03M Market Cap
- P/E Ratio
- Div Yield
435 Volume
- Eps
$ 0.6
Previous Close Want to track EGRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eagle Pharmaceuticals, Inc. (EGRX) Statistics
Valuation metrics
Market Cap 8.03M
Enterprise value 13.78M
Trailing P/E (ttm) 0.04
Forward P/E 0.07
PEG ratio -0
Price/Sales (ttm) 0
Price/Book (mrq) 0.01
Enterprise Value/Revenue 0.04
Enterprise Value/EBITDA 0.18
Overview
Shares outstanding 13.09M
Float 5.91M
Shares short 350.53K
% Held by insiders -
% Held by institutions 0.55%
Average volume (10 days) 1.8K
Average volume (90 days) 901
Price summary
52-Week low 0.09
52-Week high 3.87
Beta 0.31
50-Day moving average 0.48
200-Day moving average 0.38
Financials
Fiscal year
Fiscal year ends 31 Dec 2022
Most recent quarter (mrq) 30 Jun 2023
Profitability
Profit margin 0.11%
Operating margin 0.26%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.17%
Income Statement
Revenue (ttm) 257.55M
Revenue per share (ttm) 24.48
Quarterly revenue growth (yoy) -0.13%
Gross profit (ttm) 179.88M
EBITDA 56.28M
Net income to common (ttm) 11.95M
Diluted EPS (ttm) 2.76
Quarterly earnings growth (yoy) -0.13%
Balance Sheet
Total cash (mrq) 15.35M
Total cash per share (mrq) 4.28
Total debt (mrq) 72.45M
Total Debt/Equity (mrq) 0.29
Current ratio (mrq) 1.7%
Book value per share (mrq) 18.06
Cash Flow
Cash flow statement -9.32M
Levered free cash flow (LFCF) 38.31M
